Article RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- A Newly Discovered Dural Venous Sinus of the Skull Base: The Anterior Petroclinoid Sinus
- A newly reported muscle: an accessory infraspinatus or a deep layer of the latissimus dorsi?
- A Nonexercise Prediction of Peak Oxygen Uptake for Patients With Cardiovascular Disease DATA FROM THE FITNESS REGISTRY AND THE IMPORTANCE OF EXERCISE INTERNATIONAL DATABASE (FRIEND)
- A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury
- A novel combination of insulin degludec and liraglutide, IDegLira, enables patients with Type 2 diabetes to reach target glycaemic control faster than its individual components alone
- A Novel Computation Model of the Carotid Artery to Determine Fluid Dynamic Effects on Plaque Instability
- A Novel Direct Pathway of Dural Venous Outflow from the Basilar Venous Plexus via the Diploic Space of the Clivus
- A NOVEL HCC WAITLIST DROPOUT SCORE: BIOMARKER INTEGRATED DROPOUT GRADIENT ESTIMATION (BRIDGE)
- A Novel Mutation in ATP7B Gene: A Rare Manifestation of Wilson's Disease With Liver Failure
- A novel paradigm in the clinical context of rheumatoid arthritis: role of Tfh and Th17 Cells in autoimmunity
- A Novel Paradigm in the Clinical Context of Rheumatoid Arthritis: Role of Tfh and Th17 Cells in Autoimmunity
- A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis
- A novel sacral neuromodulation protocol is associated with reduction in removal for device infection
- A novel swine model of abdominal aortic aneurysm
- A Novel Technique for Performing Transfemoral Transcatheter Self- Expanding Aortic Valve Replacement With No Contrast Which Minimizes Acute Kidney Injury
- A Novel Wound Retractor Combining Continuous Irrigation and Barrier Protection Reduces Incisional Contamination in Colorectal Surgery
- A patient-derived orthotopic xenograft model for drugs targeting RCC metastasis: identifying personalized therapeutic strategies
- A pediatric surgeon's dilemma: does cholecystectomy improve symptoms of biliary dyskinesia?
- A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile
- A Pesco-Mediterranean Diet With Intermittent Fasting JACC Review Topic of the Week
- A Ph-Ib study of TRK-950 combined with anti-cancer treatment regimens in patients with advanced solid tumors
- A phase 1/2 study evaluating the efficacy and safety of the oral CXCR4 inhibitor X4P-001 in combination with axitinib in patients with advanced renal cell carcinoma.
- A phase 1/2 study with open-label, dose escalation phase followed by single-arm expansion at the maximum tolerated dose to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of NT219 injection alone and in combination with cetuximab in adults with advanced solid tumors and head and neck cancer.
- A Phase 1a/b Trial of Luxeptinib (CG-806) in Patients with Relapsed/Refractory B-Cell Malignancies or Acute Myeloid Leukemia and Evaluation of New G3 Formulation
- A Phase 2 Study of Actinium-225 (Ac-225)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 mu ci/Kg/Dose
- A Phase 2/3, Randomized, Open-Label Study of Bempegaldesleukin Plus Pembrolizumab vs. Pembrolizumab Alone in First-Line Treatment of Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma with PD-L1-Expressing Tumors (PROPEL-36)
- A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study
- A phase I cancer clinical trial for 4-demethyl-4cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) IND 68.876
- A Phase I clinical trial: Use of 4-demethyl-4-cholesteryl-oxycarbonyl-penclomedine (DM-CHOC-PEN) plus radiation as treatments for cancers involving the CNS
- A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies